Introduction {#s1}
============

Eukaryotic chromatin is decorated with a wide range of reversible histone post-translational modifications (PTMs) that regulate all processes that require access to DNA, including transcription, DNA replication and DNA repair ([@bib1]; [@bib7]). Actively transcribed genes in all eukaryotes are enriched in monoubiquitinated histone H2B, which plays a non-degradative role in promoting transcription ([@bib21]; [@bib81]) but whose mechanism of action remains poorly understood. Monoubiquitin is conjugated to H2B-K123 in yeast and H2B-K120 in humans, which lie near the C-terminus of histone H2B ([@bib62]; [@bib81]; [@bib82]). Monoubiquitination of histone H2B is highly dynamic ([@bib27]), and the cycle of ubiquitination and subsequent deubiquitination is an important checkpoint for transcription elongation ([@bib4]). H2B-K123 ubiquitination is required for methylation of histone H3K4 ([@bib9]; [@bib14]) and H3K79 ([@bib52]), two other marks correlated with actively transcribed genes. However, H2B-Ub also plays a role in promoting transcription that is independent of cross-talk with histone H3 methylation ([@bib72]). In addition to its role in transcription, H2B-Ub plays a role in replication fork progression, nucleosome assembly during DNA replication ([@bib52]) and the DNA damage response ([@bib24]; [@bib51]; [@bib75]). Dysregulation of histone H2B monoubiquitination has been linked to a variety of cancers ([@bib12]; [@bib18]; [@bib26]).

In the yeast, *Saccharomyces cerevisiae*, histone H2B-K123 is monoubiquitinated by the E2/E3 pair, Rad6/Bre1 ([@bib29]; [@bib62]; [@bib87]), and deubiquitinated by two deubiquitinating enzymes (DUBs): Ubp8 and Ubp10 ([@bib13]; [@bib23]; [@bib27]). Both of these DUBs belong to the Ubiquitin Specific Protease (USP) class of cysteine proteases, which contain a characteristic USP catalytic domain ([@bib38]). Ubp10 is a monomeric enzyme whereas Ubp8 is part of a four-protein subcomplex within the SAGA complex called the DUB module, which comprises Ubp8, Sgf11, Sus1, and Sgf73 ([@bib27]; [@bib37]; [@bib64]). Both yeast H2B-Ub DUBs are conserved in humans. USP36, the human homologue of Ubp10, can complement the effects of a *ubp10* deletion on global H2B-Ub in yeast ([@bib60]) and USP22, the homologue of Ubp8, is a subunit of human SAGA ([@bib92]). Yeast in which both Ubp10 and Ubp8 have been deleted showed a synergistic increase in the steady-state levels of global H2B-Ub, as well as growth defects ([@bib17]). While the roles of Ubp10 and Ubp8 in regulating H2B deubiquitination are well-established, their respective contributions to chromatin-mediated processes are poorly understood.

Despite their shared substrate specificity, Ubp8 and Ubp10 appear to play distinct roles in vivo. Several studies have shown that SAGA/Ubp8 primarily acts on H2B-Ub near promoters and transcription start sites to promote transcription initiation by RNA polymerase II ([@bib4]; [@bib13]; [@bib67]). Ubp10 was first identified for its role in regulating sub-telomeric gene silencing ([@bib17]; [@bib23]; [@bib34]) and is recruited to silenced chromatin ([@bib23]). However, deletion of *UBP10* alters expression of hundreds of yeast genes as well as H2B ubiquitination genome-wide ([@bib23]; [@bib53]; [@bib67]), indicating that Ubp10 plays a global role beyond its function in subtelomeric transcriptional repression. Deletion of *UBP8* also alters transcription of several hundred genes ([@bib23]), although an analysis of the data shows little correlation between the genes whose expression is impacted by *ubp8* versus *ubp10* deletion ([Figure 1](#fig1){ref-type="fig"}). The different impacts on transcription profiles suggest that these two H2B-Ub DUBs have distinct genomic targets. However, SAGA/Ubp8 was recently shown to be involved in transcription of all RNA polymerase II genes ([@bib2]; [@bib80]) and Ubp10 has been found in association with RNA polymerase II ([@bib44]), suggesting that both DUBs may at least be present at all genes. A partial resolution of this conundrum comes from a genome-wide ChIP-on-chip study of H2B-Ub in *ubp10* and *ubp8* deletion strains ([@bib67]) which shows that loss of *UBP8* results in an enrichment of H2B-Ub primarily near transcription start sites (TSS), whereas a *ubp10* deletion strain shows broader enrichment of H2B-Ub in mid-coding regions of longer transcription units. The ChIP results suggest that Ubp8 and Ubp10 are required during transcription, but at different times and in different genic locations. However, it remains unclear how each of these factors produces these distinct profiles and what roles each enzyme plays during these processes.

![Deletion of the *UBP8* and *UBP10* genes have different effects on transcription programs.\
Analysis of transcription data from [@bib23]. Scatter plots of the log~2~ fold change in transcript level relative to WT (log~2~FC) are shown for (top panel) a catalytically dead allele (*ubp10-C371S*) vs a deletion (*ubp10∆*) to demonstrate reproducibility of the array, and (bottom panel) a *ubp8∆* strain compared with *ubp10∆*. The two null mutants give a strong correlation (Pearson correlation coefficient r = 0.86, linear regression R^2^ = 0.74, m = 0.99), validating the reproducibility of the arrays. Deleting *UBP8* affected the transcription of different genes, resulting in poor correlation with *ubp10∆* (r = 0.055, R^2^ = 0.0031, m = 0.039).](elife-40988-fig1){#fig1}

Ubiquitination of histone H2B has been reported to assist recruitment of the histone chaperone, FACT (Facilitates Chromatin Transcription) to active chromatin ([@bib21]). The yeast FACT complex is composed of a heterodimer of Spt16 and Pob3 that is assisted in vitro and in vivo by the DNA binding protein, Nhp6 ([@bib8]; [@bib63]; [@bib66]; [@bib85]; [@bib84]). FACT is reported to evict H2A/H2B heterodimers in front of the transcription machinery ([@bib61]) and reassemble the heterodimers in the wake of RNA polymerase II to prevent cryptic transcription initiation ([@bib21]; [@bib45]; [@bib46]; [@bib58]). The disruption of the H2B ubiquitination cycle or a mutation in the FACT subunit, Spt16, causes a defect in Pol II elongation ([@bib21]). In addition to roles in transcription, FACT and H2B-Ub are each also implicated in DNA replication ([@bib22]; [@bib39]; [@bib73]). H2B-Ub at replication origins is thought to stabilize the parental nucleosomes after the passage of DNA polymerase ([@bib73]). FACT and H2B-Ub play an important role in the progression of DNA replication, likely by maintaining chromatin stability and orchestrating nucleosome assembly on newly-synthesized DNA ([@bib40]; [@bib73]). It is clear that both FACT and H2B-Ub play a pivotal role in stabilizing and assembling nucleosomes in the wake of polymerases during replication and transcription. However, it is not known how FACT and H2B-Ub status affect one another to perform these functions.

We report here a novel role for the histone chaperone, FACT, in stimulating the H2B deubiquitination activity of Ubp10 on nucleosomes. We show that the rate of deubiquitination of yeast H2B-Ub is slower when incorporated into nucleosomes as compared to free H2A/H2B-Ub heterodimers, but that the addition of FACT reverses this block. This behavior is in marked contrast to the Ubp8/DUB module, which has robust activity on both heterodimers and intact nucleosomes and is not affected by FACT ([@bib50]). We show that a yeast strain with a FACT deficiency has elevated levels of H2B-Ub, indicating that FACT also stimulates deubiquitination of H2B in vivo. Deleting Ubp10, but not Ubp8, from a strain with mutated FACT conferred strong sensitivity to the DNA replication toxin, hydroxyurea (HU), and activated a cryptic transcription reporter. Our findings suggest that the differential effects of Ubp10 and Ubp8 on the distribution of H2B-Ub result from a global role for Ubp10 and FACT versus a local role of Ubp8/SAGA at promoters and transcription start sites. These observations have important implications for the way in which cycles of H2B ubiquitination and deubiquitination regulate nucleosome dynamics during transcription and DNA replication.

Results {#s2}
=======

Ubp10 preferentially deubiquitinates free yeast H2A/H2B-Ub relative to nucleosomes {#s2-1}
----------------------------------------------------------------------------------

During transcription, nucleosomes are at least partially disassembled in order to enable RNA polymerase to access the DNA template and are then reassembled in the wake of the transcribing polymerase. It is not known when during this process ubiquitin is conjugated to histone H2B and when it is removed by either Ubp8/SAGA or Ubp10. Since histone H2A/H2B heterodimers can be ejected and re-inserted during the dynamic nucleosome disassembly and reassembly that accompanies passage of RNA polymerase, it is formally possible that H2B is deubiquitinated when it is in an intact nucleosome, after ejection to the free H2A/H2B-Ub dimer form, or when the nucleosome is in an intermediate state of disassembly or assembly. We previously reported that the Ubp8/SAGA DUB module deubiquitinates H2B in the context of both the nucleosome and the free H2A/H2B-Ub heterodimers, with a modest preference for nucleosomes ([@bib50]). Those results suggested that Ubp8/SAGA could deubiquitinate H2B at any point during transcription.

Since Ubp10 has been reported to associate with RNA polymerase II ([@bib44]) and to deubiquitinate H2B in gene bodies ([@bib67]), we asked whether this monomeric DUB discriminates between H2B-ubiquitinated nucleosomes and ubiquitinated H2A/H2B-Ub heterodimers. Using an intein-based semisynthetic approach, we generated ubiquitinated yeast histone H2B in which the C-terminus of ubiquitin was linked to H2B-K123 via a native isopeptide linkage ([@bib33]; [@bib42]). This H2B-Ub was used to reconstitute nucleosomes and H2A/H2B-Ub heterodimers. Remarkably, Ubp10 cleaved ubiquitin from H2A/H2B-Ub heterodimers at least 100-fold faster than from nucleosomes containing H2B-Ub ([Figure 2A](#fig2){ref-type="fig"}). Under the conditions tested, the majority of H2A/H2B-Ub was consumed in less than 5 min while almost all of the NCP-Ub remains uncleaved after 60 min. Similar behavior was recently observed in experiments using human histones containing a cleavable analogue of a native isopeptide linkage and a GST-Ubp10 fusion ([@bib93]). Taken together, our results indicate that Ubp10 discriminates between freestanding histone heterodimers and those in nucleosomes ([Figure 2A](#fig2){ref-type="fig"}) whereas Ubp8/SAGA does not ([@bib50]).

![Ubp10 preferentially deubiquitinates H2A/H2B-Ub over nucleosomal (NCP) H2B-Ub.\
(**A--B**) Comparison of Ubp10 activity on H2A/H2B-Ub and NCP-Ub in the absence (**A**) and presence of FACT (**B**). In panel A, 1 µM NCP-Ub and 2 µM H2A/H2B-Ub were incubated with 5 nM Ubp10 and time points were taken by quenching with SDS sample buffer. (**B**) FACT stimulates Ubp10 activity on NCP-Ub. Ubp10 activity was measured as in A, but in the presence of FACT subunits, 2 µM Spt16/Pob3-WT and 2 µM Nhp6. (**C**) The fraction of total substrate consumed over time from assays performed in A-B is shown. The plot was generated by averaging the relative intensity of H2B-Ub bands as compared with uncleaved H2B-Ub at t = 0 from three independent experiments (mean normalized band intensity and standard deviation shown). (**D**) Increasing the concentration of FACT increases the activity of Ubp10. Enzyme activity was monitored by mixing 1 µM NCP-Ub, 2 µM Nhp6, and the indicated concentrations of Spt16/Pob3 in the presence of 5 nM Ubp10. Each reaction was quenched at 60 min.](elife-40988-fig2){#fig2}

FACT stimulates Ubp10 DUB activity on nucleosomes {#s2-2}
-------------------------------------------------

In cells, core histones that are not incorporated into nucleosomes are usually bound by histone chaperones, which bind to H2A/H2B heterodimers or H3/H4 heterodimers or heterotetramers ([@bib16]). The histone chaperone, FACT, binds to H2A/H2B heterodimers and facilitates heterodimer eviction and exchange, as well as nucleosome reassembly ([@bib21]; [@bib46]; [@bib54]; [@bib55]; [@bib65]). In light of the reported functional interaction between H2B-Ub and FACT ([@bib21]; [@bib58]) and the role of FACT in binding both H2A/H2B heterodimers and intact nucleosomes, we asked whether Ubp10 can remove ubiquitin from ubiquitinated yeast H2A/H2B heterodimers or nucleosomes when they are bound to FACT. We unexpectedly found that FACT dramatically increases the rate at which Ubp10 cleaves H2B-Ub in nucleosomes ([Figure 2B--C](#fig2){ref-type="fig"}). Essentially all of the H2B-Ub in the nucleosomal sample was cleaved in under 60 min in the presence of FACT ([Figure 2B--C](#fig2){ref-type="fig"}), whereas less than 10% was consumed during the same time period in the absence of FACT ([Figure 2A--C](#fig2){ref-type="fig"}). By contrast, the addition of FACT had no effect on the rate at which Ubp10 deubiquitinated H2B in H2A/H2B-Ub heterodimers ([Figure 2A--B](#fig2){ref-type="fig"}). We verified that purified FACT on its own has no DUB activity against the ubiquitinated nucleosome ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To further confirm the dependence of Ubp10 DUB activity on the presence of FACT, we assayed Ubp10 deubiquitination activity on nucleosomes at a fixed time point in the presence of increasing concentrations of FACT. As shown in [Figure 2D](#fig2){ref-type="fig"}, the amount of nucleosomal H2B-Ub cleaved increases as a function of increasing FACT concentration. Notably, the dose response for FACT in this assay closely matches the affinity of FACT for nucleosomes ([@bib63]; [@bib83]). Interestingly, the ability of FACT to stimulate of H2B deubiquitination does not require Nhp6, as Spt16/Pob3 alone efficiently stimulates the activity of Ubp10 ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). These results show that FACT stimulates Ubp10 DUB activity, and that this stimulatory effect is specific to nucleosomal H2B-Ub substrates.

A possible explanation for the observed stimulatory effect of FACT is that it alters nucleosomal structure, making it a better substrate for Ubp10. Previous studies have shown that FACT binding can destabilize canonical nucleosomes, disrupting the octamer/DNA contacts, which could result in displacement of H2A/H2B heterodimers ([@bib5]; [@bib10]; [@bib48]), thereby providing better substrates for Ubp10 ([Figure 2](#fig2){ref-type="fig"}). During nucleosome reorganization induced by FACT, surfaces of H2A/H2B heterodimers that are buried in the context of the nucleosome become more accessible ([@bib36]) even while the components remained tethered together ([@bib79]; [@bib88]; [@bib90]), which could enhance accessibility of H2B-Ub for deubiquitination by Ubp10 without dimer eviction. We therefore tested the simple model in which binding of DNA to H2A/H2B heterodimers creates a barrier to Ubp10 deubiquitination of H2B-Ub. However, the activity of Ubp10 on H2A/H2B-Ub heterodimers was similar in the presence and absence of 601 DNA ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). This experiment does not rule out steric hindrance by DNA in the context of the full histone octamer, but leaves open the possibility that reorganization of the nucleosome by FACT exposes surfaces more favorable to Ubp10 docking on H2B-Ub. Displacement of H2A/H2B-Ub from nucleosomes does not appear to be required, as deubiquitination by Ubp10 was stimulated by FACT without altering the integrity of nucleosomes as judged by native gel electrophoresis ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). Moreover, Nhp6 is required for full reorganization of nucleosomes by FACT ([@bib49]) but did not affect the nucleosomal forms produced after deubiquitination.

The finding that FACT stimulates Ubp10 to deubiquitinate nucleosomes stands in stark contrast to the Ubp8/SAGA DUB module. We previously found ([@bib50]) that the abillity of the Ubp8/DUB module to deubiquitinate nucleosomes is not affected by the addition of FACT. SAGA/Ubp8 can therefore access H2B-K123Ub in the context of the nucleosome, but Ubp10 deubiquitinates nucleosomal H2B-Ub poorly without the assistance of FACT.

FACT stimulation does not correlate with Ubp10 nucleosome-binding activity {#s2-3}
--------------------------------------------------------------------------

Ubp10 contains an unstructured region rich in Asp/Glu that is N-terminal to the catalytic USP domain (residues 362--733) ([@bib60]) ([Figure 3A](#fig3){ref-type="fig"}). The N-terminal unstructured region contains residues that interact with the Sir3/Sir4 silencing proteins and recruit Ubp10 to subtelomeric regions ([@bib17]; [@bib23]; [@bib93]). However, it is not known how Ubp10 is recruited to ubiquitinated nucleosomes elsewhere in the genome. We therefore asked whether Ubp10 alone can bind to nucleosomes in which ubiquitin is linked to H2B-K123 via a non-hydrolyzable linker ([@bib50]). We detected binding of Ubp10 to ubiquitinated nucleosomes in an electrophoretic mobility shift assay (EMSA), with half-maximal binding observed at approximately 0.4 µM Ubp10 ([Figure 3B](#fig3){ref-type="fig"}). Ubp10 bound with similar apparent affinity to unmodified nucleosomes ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), indicating that interactions between the ubiquitin and the Ubp10 catalytic domain do not play a significant role in the observed binding. Deletion of the N-terminal 156 residues had little effect on the affinity of Ubp10 for ubiquitinated nucleosomes ([Figure 3B](#fig3){ref-type="fig"}). However, a further deletion of the N-terminal 199 residues, Ubp10-(200-792), reduced binding substantially, and no binding was detected with Ubp10 residues 250--792 ([Figure 3B](#fig3){ref-type="fig"}). The Sir3/Sir4 interaction domain has been mapped to Ubp10 residues 109--133 ([@bib60]) so these results show that the Asp/Glu rich region (residues 157--250) of Ubp10 is important for the observed binding to nucleosomes but the Sir3/Sir4 binding site is not.

![FACT stimulates Ubp10 constructs that lack intrinsic ability to bind nucleosomes.\
(**A**) Schematic of Ubp10 and its truncations with the locations of the catalytic domain (USP) and an N-terminal region rich in aspartic acid and glutamic acid repeats shown. (**B**) Native gel showing complexes formed between Ubp10 constructs and ubiquitinated nucleosomes (purified proteins used in this experiment are shown in [Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). (**C**) Ubp10 activity was measured as in [Figure 2](#fig2){ref-type="fig"}; time points were taken after incubating 2 µM H2A/H2B-Ub dimers with 5 nM Ubp10 fragments. (**D**) NCP-Ub cleavage activity monitored in the presence and absence of FACT and several Ubp10 constructs.](elife-40988-fig3){#fig3}

To determine whether Ubp10 domains that are required for nucleosome binding are also required for DUB activity as well as for stimulation by FACT, we tested the DUB activity of the Ubp10 N-terminal truncations. All three N-terminal truncation mutants were active on H2A/H2B-Ub heterodimers, although the Δ200 and Δ250 truncations had slightly lower activity than intact Ubp10 ([Figure 3C](#fig3){ref-type="fig"}). Similar to the full length protein, all three truncations displayed weak activity on a nucleosomal substrate in the absence of FACT and enhanced DUB activity on nucleosomes in the presence of FACT ([Figures 3D](#fig3){ref-type="fig"} and [2A](#fig2){ref-type="fig"}). Therefore, the truncations that decreased Ubp10 affinity for nucleosomes (Ubp10 200--792 and Ubp10 250--792) were still stimulated by FACT. We also tested the hypothesis that the presence of FACT might enhance binding of Ubp10 to nucleosomes, which could provide a mechanism by which FACT enhances cleavage of nucleosomal H2B-Ub. Gel mobility shift assays for binding to ubiquitinated nucleosomes, however, did not show enhanced affinity of Ubp10 for ubiquitinated nucleosomes in the presence of FACT ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). These results suggest that the ability of FACT to stimulate Ubp10 is not coupled to the intrinsic ability of Ubp10 to bind nucleosomes. We speculate that Ubp10 binds to nucleosomes primarily through the histone dimers but remains poised for deubiquitination until FACT acts on the nucleosomes.

A FACT mutant strain has elevated levels of H2B-Ub {#s2-4}
--------------------------------------------------

Our in vitro assays show that the ability of Ubp10 to deubiquitinate nucleosomes is greatly enhanced in the presence of the histone chaperone FACT ([Figure 2](#fig2){ref-type="fig"}). If FACT activity also stimulates Ubp10 activity in vivo, a defect in FACT activity should phenocopy the effects of a Ubp10 deletion. To test this, we compared the relative ratio of monoubiquitinated H2B to unmodified H2B in a yeast strain with the *pob3-L78R* mutation, which destabilizes the Pob3 subunit of FACT and reduces its level by about 10-fold under permissive growth conditions ([@bib66]; [@bib77]). This causes defects in both transcription and DNA replication ([@bib66]). As shown in [Figure 4](#fig4){ref-type="fig"}, the *pob3-L78R* strain had an elevated level of H2B-Ub (1.9-fold increased) that is comparable to that in a *ubp10* deletion strain (1.4-fold increased) when normalized for total H2B. This increase in H2B-Ub in a FACT mutant is consistent with a role for FACT in deubiquinating H2B-Ub in vivo. A strain lacking Ubp10 and also carrying the FACT defect had roughly the same increased ratio of H2B-Ub as the *pob3-L78R* mutant (2.0-fold increased, [Figure 4B](#fig4){ref-type="fig"}), consistent with the interpretation that FACT and Ubp10 cooperate to deubiquitinate H2B in the same pathway. Together, these results show that FACT activity can contribute to H2B deubiquitination in vivo, supporting the physiological relevance of the in vitro data showing that FACT is stimulates Ubp10 activity on nucleosomes ([Figure 2D](#fig2){ref-type="fig"}).

![H2B-Ub levels are elevated in a FACT mutant strain.\
(**A**) Representative western blot analysis of TCA extracts from *WT*, *ubp10Δ,* and *ubp10Δ pob3-L78R* strains probed with antibodies against H2B-Ub and re-probed with antibodies against H2B. (**B**) Relative steady-state levels of H2B-Ub for *WT*, *pob3-L78R, ubp10Δ, and ubp10Δ/pob3-L78R* strains ([Table 1](#table1){ref-type="table"}). The average and standard deviation from multiple biological replicates is shown. The numbers at the bottom indicate the relative H2B-Ub increase normalized to the paired unmodified H2B value (H2B-Ub/H2B) within each individual gel. Total H2B is decreased in the mutant because the slow growth of the strain leads to a larger average cell size and therefore a lower contribution of nuclear proteins to the total protein level that was used to normalize loading.](elife-40988-fig4){#fig4}
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###### Yeast Strains used All strains are congenic with the A364a background and are *MATa.*

Standard methods were used to introduce the mutations shown into diploid strains, then haploids were derived and crossed to obtain the combinations listed, ensuring that all strains with the same genotype displayed the phenotypes observed.

  [Figure 4](#fig4){ref-type="fig"} Western blots                                                                     
  --------------------------------------------------------------------------------------------- --------------------- -----------------------------------------------------------------------------------------------------------
  8127-7-4                                                                                      WT                    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂*
  10018-1-4                                                                                     *ubp10∆*              *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(::KanMX)*
  9204                                                                                          *pob3-L78R*           *ura3 leu2 trp1 his3 lys2-128∂ pob3-L78R(+34, LEU2)*
  10025-2-4                                                                                     *pob3-L78R ubp10∆*    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(::HphMX) pob3-L78R(+34, LEU2)*
  [Figure 5A](#fig5){ref-type="fig"} (top panel), [Figure 6A](#fig6){ref-type="fig"} (1-4)                            
  8127-7-4                                                                                      WT                    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂*
  10018-1-4                                                                                     *ubp10∆*              *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(::KanMX)*
  9204                                                                                          *pob3-L78R*           *ura3 leu2 trp1 his3 lys2-128∂ pob3-L78R(+34, LEU2)*
  10025-2-4                                                                                     *pob3-L78R ubp10∆*    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(::HphMX) pob3-L78R(+34, LEU2)*
  [Figure 5C](#fig5){ref-type="fig"} (middle panel), [Figure 6A](#fig6){ref-type="fig"} (5-8)                         
  8127-7-4                                                                                      WT                    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂*
  8540-1-1                                                                                      *ubp8∆*               *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp8-∆(::KanMX)*
  9204                                                                                          *pob3-L78R*           *ura3 leu2 trp1 his3 lys2-128∂ pob3-L78R(+34, LEU2)*
  10032-4-3                                                                                     *pob3-L78R ubp8∆*     *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ pob3-L78R(+34, LEU2) ubp8-∆(::KanMX)*
  [Figure 5B](#fig5){ref-type="fig"} (bottom panel), [Figure 6B](#fig6){ref-type="fig"}                               
  8127-7-4                                                                                      WT                    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂*
  10018-1-4                                                                                     *ubp10∆*              *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(::KanMX)*
  9273H                                                                                         *pob3-Q308K*          *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ pob3-Q308K(+34, HphMX)*
  10019-2-3                                                                                     *pob3-Q308K ubp10∆*   *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ pob3-Q308K(+34, HphMX) ubp10-∆(::KanMX)*
  9495 H-2-3                                                                                    *spt16-11*            *ura3 leu2 trp1 his3 lys2-128∂ spt16-11(+124, HphMX)*
  [Figure 6C](#fig6){ref-type="fig"}                                                                                  
  9880-2-2                                                                                      WT                    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX)*
  10040-3-2                                                                                     *ubp8∆*               *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) ubp8-∆(::KanMX)*
  10024-3-1                                                                                     *ubp10∆*              *ura3 leu2-∆0 trp1 his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) ubp10-∆(::HphMX)*
  10040-1-3                                                                                     *pob3-L78R*           *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) pob3-L78R(+34, LEU2)*
  10040-5-1                                                                                     *pob3-L78R ubp8∆*     *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) pob3-L78R(+34, LEU2) ubp8-∆(::KanMX)*
  10039-1-4                                                                                     *pob3-L78R ubp10∆*    *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) pob3-L78R(+34, LEU2) ubp10-∆(::HphMX)*
  9949-3-1                                                                                      *spt16-11*            *ura3 leu2 trp1 his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) spt16-11(+124, KanMX)*
  10044-4-2                                                                                     *ubp8∆ spt16-11*      *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) spt16-11 ubp8-∆(::KanMX)*
  10043-7-3                                                                                     *ubp10∆ spt16-11*     *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ GAL1pr-flo8-HIS3(NatMX) spt16-11(+124, HphMX) ubp10-∆(::KanMX)*

  11-16-2018 upb10∆(109-133) tests ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"})        
  ---------------------------------------------------------------------------------------------- ---- --------------------------------------------
  8127-7-4                                                                                       WT   *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂*

  ----------- ----------------------------- ----------------------------------------------------------------------------------
  10018-1-4   *ubp10∆*                      *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(::KanMX)*
  9204        *pob3-L78R*                   *ura3 leu2 trp1 his3 lys2-128∂ pob3-L78R(+34, LEU2)*
  10062-4-4   *pob3-L78R ubp10∆*            *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(::HphMX) pob3-L78R(+34, LEU2)*
  10064-2-1   *ubp10∆(109-133)*             *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ ubp10-∆(109-133)*
  10062-1-2   *pob3-L78R ubp10∆(109-133)*   *ura3-∆0 leu2-∆0 trp1-∆two his3 lys2-128∂ pob3-L78R(+34, LEU2) ubp10-∆(109-133)*
  ----------- ----------------------------- ----------------------------------------------------------------------------------

Our results differ from a previous study ([@bib21]) that found that cells with a temperature-sensitive *SPT16* allele (*spt16-197*) showed a decrease in FLAG-H2B-Ub levels when shifted to a restrictive temperature. In that experiment, cells initially experienced normal levels of FACT, followed by an acute reduction of the essential FACT complex to a level that does not support viability ([@bib43]). By contrast, the *pob3-L78R* mutant used in this study experiences chronically low levels of FACT but is viable under the conditions tested ([@bib66]). The use of an allele that destabilizes a different subunit of FACT under conditions of chronic rather than acute exposure to FACT depletion may explain the different outcomes, and may suggest clues regarding the mechanism through which FACT affects Ubp10 activity in vivo.

FACT and Ubp10 cooperate during DNA replication {#s2-5}
-----------------------------------------------

In addition to their roles in transcription ([@bib4]; [@bib21]; [@bib58]; [@bib61]; [@bib81]), both FACT and H2B monoubiquitination have been implicated in assembling and stabilizing nucleosomes during DNA replication ([@bib31]; [@bib40]; [@bib73]). FACT has been proposed to play an important role in DNA replication by assisting in initiation, DNA unwinding, histone eviction, and chromatin reassembly ([@bib40]; [@bib59]; [@bib66]; [@bib73]). H2B monoubiquitination near origins of replication supports replisome stability, fork progression and checkpoint pathways ([@bib40]; [@bib73]). Insights into the role of H2B-Ub in DNA replication come from studying the effects of deleting the H2B E3 ligase, Bre1 ([@bib40]; [@bib73]), or mutants expressing H2B with a K123R substitution, which cannot be ubiquitinated ([@bib40]; [@bib73]). The role of H2B deubiquitinating enzymes in DNA replication, however, has not been explored.

In light of our finding that FACT stimulates Ubp10 activity on nucleosomes in vitro and is required to maintain wild type levels of H2B ubiquitination in vivo, we asked whether FACT functionally interacts with Ubp10 during DNA replication. We tested the sensitivity of Ubp10 deletions and FACT mutants to hydroxyurea, which depletes cellular dNTPs and induces replication fork stalling ([@bib70]). The *pob3-L78R* FACT mutant has previously been shown to display a severe growth defect at 30° (temperature sensitivity) but is viable at 25°C ([@bib66]), while the *ubp10∆* strain has a mild growth defect and is not temperature sensitive ([@bib23]). Growth of the *ubp10∆/pob3-L78R* double mutant at 25°C was only mildly reduced relative to the single mutants ([Figure 5A](#fig5){ref-type="fig"}). Neither the *ubp10∆* nor the *pob3-L78R* FACT mutant was sensitive to 90 mM hydroxyurea ([Figure 5A](#fig5){ref-type="fig"}). However, the double *ubp10∆/pob3-L78R* mutant displayed a significant growth defect under these or milder conditions, with a synthetic defect observed even at levels of HU as low as 6 mM ([Figure 5A](#fig5){ref-type="fig"}). To test whether this synthetic growth defect in the presence of HU is unique to the *pob3-L78R* FACT mutant, we also examined the genetic interaction between a *ubp10* deletion and two other FACT mutants, *spt16-11* and *pob3-Q308K*. As shown in [Figure 5B](#fig5){ref-type="fig"}, both the *spt16-11* and *pob3-Q308K* mutants displayed synthetic growth defects in the presence of HU when combined with a *ubp10* deletion.

![Combining *ubp10∆* and FACT alleles causes sensitivity to HU.\
(**A--C**) Strains indicated ([Table 1](#table1){ref-type="table"}) were grown to saturation, then 10-fold serial dilutions were spotted on rich medium (YPAD) with and without the indicated concentrations of hydroxyurea (HU, mM). Plates were incubated at the temperature indicated for the time shown (days). Combining *pob3-L78R* with *ubp10∆* caused HU sensitivity (**A**), but combining it with *ubp8∆* did not (**C**). Combining *ubp10∆* with other alleles of FACT also caused synthetic defects on HU (**B**).](elife-40988-fig5){#fig5}

Ubp8/SAGA, in contrast to Ubp10, does not depend upon FACT to deubiquitinate nucleosomes in vitro ([@bib50]). We therefore predicted that *ubp8* and FACT should not have the same genetic interaction as *ubp10* and FACT. Indeed, a *ubp8∆/pob3-L78R* double mutant did not show any synthetic growth defects in the presence of hydroxyurea, even at concentrations as high as 150 mM ([Figure 5C](#fig5){ref-type="fig"}). These observations point to a specific cooperative function of Ubp10 and FACT in DNA replication that cannot be performed by Ubp8.

FACT and Ubp10 cooperate to suppress cryptic transcription {#s2-6}
----------------------------------------------------------

Both FACT and H2B ubiquitination are needed to maintain wild type levels of nucleosome occupancy ([@bib20]; [@bib21]; [@bib30]). Defects in nucleosome occupancy can give rise to altered transcription patterns and activation of cryptic transcription initiation in gene coding regions ([@bib21]; [@bib35]). Mutations in FACT cause expression of the *lys2-128∂* Spt^--^ phenotype reporter ([S]{.ul}u[p]{.ul}pression of [T]{.ul}y1 insertion) ([@bib8]; [@bib43]; [@bib66]; [@bib69]), which reveals failure to establish normal chromatin-mediated repression of this promoter ([@bib11]; [@bib35]). Wild type strains with this reporter have normal chromatin and do not grow on medium lacking lysine, but all three FACT mutants tested here express the reporter and grow (called the Spt^--^ phenotype; [Figure 6](#fig6){ref-type="fig"}). This readout of transcription initiation resulting from poor quality chromatin was not affected by the loss of Ubp10 ([Figure 6A,B](#fig6){ref-type="fig"}; the growth defects caused by combining *ubp10∆* with FACT mutations were similar on -lys and complete media so they are not due to changes in the Spt^--^ phenotype) or loss of Ubp8 ([Figure 6A](#fig6){ref-type="fig"} and not shown). We then tested the effect of *ubp10Δ* on expression of a cryptic promoter reporter, which supports growth in the absence of histidine if galactose-induced transcription of the reporter activates a cryptic promoter within the *FLO8* gene ([@bib11]) ([Figure 6D](#fig6){ref-type="fig"}). While neither a *ubp10∆* nor an *spt16-11* mutant activated the reporter gene, the double *ubp10∆/spt16-11* mutant displayed significant levels of cryptic promoter activation (compare Gal Complete and Gal -his in [Figure 6C](#fig6){ref-type="fig"}) whereas the double *ubp8∆/spt16-11* mutant did not. We were not able to see an effect of combining a *ubp10Δ* with the *pob3-L78R* allele because the *pob3-L78R* mutation on its own robustly activates the cryptic transcription reporter and enables near wild-type levels of growth ([Figure 6C](#fig6){ref-type="fig"}), again highlighting the different effects of different FACT alleles. Taken together, these results indicate that Ubp10, but not Ubp8, acts in combination with FACT to maintain normal chromatin organization in the wake of RNA polymerase II transcription.

![Combined effect of FACT mutants and *ubp10∆* or *ubp8∆* deletions on the Spt^--^ phenotype and cryptic promoter activation.\
(**A,B**) *ubp10∆* did not affect the Spt^--^ phenotype of FACT mutants. Dilutions of the same strains shown in [Figure 5](#fig5){ref-type="fig"} were plated on synthetic medium with (C, complete) or without lysine (-lys). These strains with the *lys2-128∂* allele are auxotrophic for lysine, but defects in chromatin integrity allow expression of the gene, which is revealed as growth on -lys (the Spt^--^ phenotype; see [@bib69]). FACT mutants displayed this phenotype, but this was not affected by *ubp8∆* or *ubp10∆* (A, B, and not shown). (**C**) Activation of a cryptic transcription reporter in a *ubp10∆/spt16-11* mutant strain reveals a defect in restoring chromatin in the wake of RNA Pol II passage. Strains with an out-of-frame fusion of *HIS3* to a site downstream of a cryptic promoter in the *FLO8* gene (panel D, adapted from [@bib11]) are auxotrophic for histidine when the *GAL1* promoter driving transcription of this reporter is repressed on glucose (not shown) but can grow without histidine on synthetic medium containing galactose (Gal -his). Strains with the *pob3-L78R* mutation have this phenotype, indicating activation of the cryptic promoter, masking any potential effects of *ubp8∆* or *ubp10∆*. The *spt16-11* allele alone did not activate this reporter but did when combined with *ubp10∆*.](elife-40988-fig6){#fig6}

Discussion {#s3}
==========

We have discovered a previously uncharacterized synergy between the H2B deubiquitinating enzyme, Ubp10, and the histone chaperone, FACT, that suggests a unifying model for the role of H2B ubiquitination and deubiquitination in nucleosome dynamics. The role of H2B monoubiquitination in recruiting FACT to nucleosomes and the importance of both FACT and H2B-Ub in transcription ([@bib4]; [@bib21]; [@bib81]) and in DNA replication ([@bib40]; [@bib73]), are well-established. However, the interplay between nucleosome dynamics, H2B deubiquitination and histone chaperones had not been explored. In this study, we report a role for the histone chaperone, FACT, in deubiquitinating H2B-Ub and show that Ubp10 depends on FACT to efficiently cleave H2B-Ub from nucleosomes ([Figure 2](#fig2){ref-type="fig"}). This behavior is unlike Ubp8/SAGA, which does not require FACT to deubiquitinate nucleosomes ([@bib50]). Consistent with our in vitro results, we find that a mutation that decreases the level of FACT (*pob3-L78R*) results in increased levels of H2B-Ub that are comparable to those caused by loss of Ubp10 ([Figure 4](#fig4){ref-type="fig"}). We also show that combining FACT mutations with loss of Ubp10, but not loss of Ubp8, causes sensitivity to hydroxyurea, suggesting a role for the FACT-Ubp10 collaboration in DNA replication. Similarly, combining FACT mutations with deletion of *UBP10*, but not *UBP8*, activates a cryptic promoter reporter gene, reflecting a role for Ubp10 in maintaining nucleosome occupancy during transcription. These combined in vivo and in vitro observations point to a role for Ubp10 and FACT in jointly maintaining chromatin organization and have important implications for the different cellular roles of the two H2B-Ub DUBs, Ubp8 and Ubp10.

Our results are consistent with a model in which Ubp10 plays a global role in regulating nucleosome dynamics in concert with FACT, while Ubp8 plays a more restricted role at sites of transcription initiation. This view is consistent with previous observations that Ubp8 deletion leads to higher levels of H2B-Ub in the vicinity of the +1 nucleosome, whereas Ubp10 deletions exhibit broader enrichment of H2B-Ub in gene bodies, particularly in longer open reading frames ([@bib67]). Ubp8 is targeted to genes in the context of the SAGA complex, a global transcription factor that associates with promoter regions of virtually all RNA polymerase II genes ([@bib2]; [@bib3]; [@bib6]; [@bib78]), which accounts for the observed pattern of H2B-Ub enrichment in *ubp8* deletion strains ([@bib67]). The genome-wide pattern of H2B-Ub enrichment found in *ubp10* deletion strains ([@bib67]) can be explained by a global function for Ubp10 in nucleosome assembly through its partnership with FACT. FACT has been implicated in transcription through its increased association with frequently transcribed genic regions ([@bib20]; [@bib47]; [@bib56]; [@bib65]), but these same studies show that it is also abundant in intergenic regions. FACT physically interacts with both the MCM replicative helicase and with DNA polymerase α, and it promotes rapid deposition of nucleosomes in an in vitro replication system ([@bib86]; [@bib89]; [@bib91]). FACT is found in yeast cells at about two-thirds the abundance of nucleosomes and therefore is a global component of chromatin that participates in a broad range of chromatin-dependent processes ([@bib25]). These roles include restoring chromatin integrity after disruptions like transcription ([@bib45]) but emerging evidence shows that FACT may have a less prominent role in proliferation of differentiated mammalian cells ([@bib25]; [@bib68]). Collectively, these findings suggest, instead, that the primary role of FACT is to stabilize or maintain existing global chromatin architectures and promote transitions to new patterns during differentiation. The finding that Ubp10, but not Ubp8, plays an unanticipated role in DNA replication ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}) and suppression of cryptic transcription ([Figure 6](#fig6){ref-type="fig"}) that overlaps with the role of FACT supports the idea that, like FACT, Ubp10 has a global function in maintaining stable chromatin architecture against a range of potential perturbations.

H2B ubiquitination has been proposed to stabilize chromatin as judged by a genome-wide reduction in nucleosome occupancy seen in mutants that lack Rad6, the E2 that ubiquitinates H2B, or in which wild type H2B is replaced by H2B-K123A, which cannot be ubiquitinated ([@bib4]). Deletion of *UBP8* enhances nucleosome occupancy genome-wide. However, the simple model that high global levels of H2B-Ub correlate with higher nucleosome occupancy is contradicted by the observation that highly transcribed genes have normal levels of nucleosome occupancy in a *ubp8∆* mutant, even though these genes have markedly lower nucleosome occupancy in *rad6∆* and H2B-K123A mutants ([@bib4]). Our finding that a double *ubp10∆/spt16-11* mutant activates a cryptic promoter points to a unique role for Ubp10 acting in concert with FACT to maintain nucleosome organization and is consistent with prior studies that suggest that cycles of both ubiquitination and deubiquitination are critical for nucleosome assembly during transcription ([@bib4]; [@bib21]; [@bib27]; [@bib58]).

In addition to its role in regulating global levels of H2B-Ub, Ubp10 regulates spreading of heterochromatic silencing at telomeres and at mating type loci ([@bib17]; [@bib23]). This function is mediated by the N-terminus of Ubp10, which is recruited by the SIR complex to subtelomeric regions ([@bib17]; [@bib23]; [@bib93]). The silencing and global H2B ubiquitination functions of Ubp10 appear to be separable, as expression of N-terminal truncations of Ubp10 can restore wild type levels of H2B ubiquitination without restoring subtelomeric silencing ([@bib60]). A recent study ([@bib93]) reported that Sir2/Sir4, a subset of the SIR complex, stimulates the activity of GST-Ubp10 on both human nucleosomes and H2A/H2B-Ub heterodimers containing a hydrolyzable non-native linkage between ubiquitin and H2B. The observed stimulation was attributed to the ability of Sir2/Sir4 to recruit Ubp10 to chromatin, as has also been observed in vivo ([@bib17]), as well as to a proposed allosteric stimulation of Ubp10 on both H2A/H2B-Ub heterodimers and on ubiquitinated nucleosomes ([@bib93]). The effect observed in that study depended on residues 109--133 of Ubp10, which do not play a role in either Ubp10 catalytic activity on yeast H2A/H2B-Ub heterodimers, the ability to be stimulated by FACT ([Figure 3](#fig3){ref-type="fig"}), or FACT function in vivo ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The effect of Sir2/Sir4 on Ubp10 thus appears to be restricted to its silencing-specific functions. Notably, human Usp15 also preferentially deubiquitinates H2A/H2B-Ub dimers and is stimulated by the splicing factor SART3 ([@bib41]), although in this case SART3 has the inverse effect: it enhances the activity of Usp15 on H2A/H2B-Ub but not on nucleosomes.

It is not clear why nucleosomes are such a poor substrate for Ubp10 as compared to H2A/H2B-Ub heterodimers. Ubp8 is targeted to nucleosomes in the context of the SAGA DUB module, in which Ubp8 forms a complex with Sgf11, Sus1 and Sgf73 ([@bib27]; [@bib37]). The specificity of Ubp8 for H2B-K123 is conferred by Sgf11, which has a zinc finger domain with an arginine-rich patch ([@bib37]; [@bib64]) that docks in the nucleosome acidic patch between histones H2A and H2B ([@bib50]). By contrast, Ubp10 is a monomeric enzyme that lacks accessory proteins that could promote binding to nucleosomes. However, Ubp10 has surprisingly high affinity for nucleosomes, binding with an apparent Kd of \~400 nM ([Figure 3B](#fig3){ref-type="fig"}). The wild-type Ubp8/DUB module, by contrast, does not bind detectably to nucleosomes by EMSA ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). The ability of Ubp10 to bind nucleosomes and the stimulation of Ubp10 enzymatic activity by FACT do not seem to be connected, as N-terminal deletions of Ubp10 that impair nucleosome binding are still stimulated by FACT ([Figure 3B--D](#fig3){ref-type="fig"}). Moreover, deletions within the N-terminal unstructured region of Ubp10 ([@bib60]), which include residues important for recruitment to telomeres by the SIR complex ([@bib34]), have little or no effect on global H2B ubiquitination ([@bib23]). The significance of the ability of Ubp10 to bind nucleosomes, which was also observed by [@bib93], and the use of nucleosomes as substrates for deubiquitination therefore remains unresolved.

How does FACT stimulate the activity of Ubp10 on nucleosomes? While there is no direct evidence that FACT and Ubp10 work together in vivo, the synthetic genetic interaction and the biochemical cooperation that we observe is consistent with such a possibility. We propose that the structural changes that occur in canonical nucleosomes upon FACT binding are likely key to addressing this question, as the observed stimulation is specific to nucleosomal substrates. FACT can reorganize the nucleosome by disrupting histone/DNA contacts, leaving the nucleosome in an 'open' or 'destabilized' state ([@bib10]; [@bib36]; [@bib48]) and by fully displacing H2A/H2B heterodimers ([@bib5]; [@bib10]; [@bib28]; [@bib55]; [@bib79]; [@bib88]). The most straightforward explanation for the effect of FACT on Ubp10 activity is therefore that FACT increases H2B deubiquitination by evicting H2A/H2B-Ub heterodimers, which are an excellent substrate for Ubp10 ([Figures 2A](#fig2){ref-type="fig"} and [3C](#fig3){ref-type="fig"}). However, H2A-H2B displacement has been estimated to be limited to 20--50% of the total heterodimers ([@bib54]; [@bib88]) and requires the addition of Nhp6 to yeast Spt16-Pob3, whereas we observe complete deubiquitination, and no requirement for Nhp6. Dimer displacement can therefore only partially explain the effect of FACT. While it is not known whether ejected H2A/H2B heterodimers retain the H2B-K123 ubiquitin modification in vivo, our in vitro results clearly show that an H2A/H2B-Ub dimer bound to FACT can be rapidly deubiquitinated by Ubp10. Alternatively, FACT may stimulate Ubp10 by partly unwinding the DNA ([@bib36]; [@bib48]; [@bib76]), generating a hexasome, or yielding some other intermediate in nucleosome disassembly that either exposes surfaces that allow Ubp10 to interact more favorably with the H2B-Ub linkage or relieves steric clashes. In this second scenario, Ubp10 deubiquitinates H2B only after FACT has begun to destabilize the nucleosome, but without complete eviction of the dimer. In support of this idea, we find that the nucleosomes are intact following deubiquitination by Ubp10 ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). In either scenario, Ubp10 must deubiquitinate H2B-Ub at some point between the time the nucleosome is destabilized and before it is reassembled in the wake of either DNA or RNA polymerase. We think it is unlikely that FACT stimulates Ubp10 by recruiting it to the nucleosome, as we see no evidence that FACT enhances Ubp10 binding ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). The enhancement of Ubp10 activity provides the first example of a physiologically relevant substrate that appears to be activated by FACT-mediated destabilization of nucleosomes. Further studies will be needed to unravel the molecular determinants governing Ubp10 substrate preference as well as the mechanism by which FACT activates deubiquitination of nucleosomes.

The coupling of Ubp10 and FACT activity provides a missing link between cycles of H2B ubiquitination and deubiquitination, and FACT activity and nucleosome disassembly and assembly that allows us to propose a global model for the role of H2B ubiquitination in chromatin dynamics ([Figure 7](#fig7){ref-type="fig"}). Ubiquitination of H2B by Rad6/Bre1 recruits FACT, which can either facilitate nucleosome disassembly or bind to nucleosomes that are already destabilized. Ubp10 then deubiquitinates H2B, enhancing the ability of FACT to promote reassembly of the nucleosome and/or reinsertion of a deubiquitinated H2A/H2B dimer. Deubiquitination of H2B could potentially favor nucleosome reassembly by enhancing release of FACT from its proposed checkpoint function ([@bib49]). The sequence of H2B ubiquitination, FACT-mediated nucleosome reorganization, then deubiquitination by Ubp10 and accelerated assembly could propel sequential assembly of nucleosomes, either in the wake of RNA polymerase or during DNA replication. This proposed sequence of events could also occur in humans, as well, given the conservation of all components of this sytem: RAD6B/RNF20/40 are the human E2/E3, USP36 is the homologue of Ubp10 and human FACT, Spt16/SSRP1, is the homologue of the yeast FACT complex, Spt16/Pob3/Nhp6. Our study provides a framework for understanding how H2B-Ub deubiquitination is coupled to the activity of the histone chaperone, FACT, in producing dynamic changes to nucleosome structure, and has exciting implications for understanding the mechanism by which dynamic cycles of ubiquitination and deubiquitination regulate chromatin organization.

![Model for coordinated H2B deubiquitination and nucleosome assembly by FACT/Ubp10 during transcription and DNA replication.\
Rad6/Bre1 ubiquitinates nucleosomal histone H2B during transcription and DNA replication. The presence of H2B-Ub recruits FACT to the nucleosome. FACT destabilizes nucleosomes or binds to nucleosomes that are already destabilized by transcription or replication factors. Ubp10 deubiquitinates H2B-Ub in the context of fully or partially exposed H2A/H2B-Ub heterodimers while still tethered to Spt16/Pob3. Deubiquitination of H2B signals passage of polymerases and deposition of histones in the wake of polymerases. The deubiquitinated nucleosome is reassembled by FACT, followed by dissociation of FACT. The full reorganization depicted here supports Ubp10 activity, but since Spt16-Pob3 heterodimers can support Ubp10 as well, activation of Ubp10 may require only the early stages of reorganization that are not dependent on Nhp6.](elife-40988-fig7){#fig7}

Materials and methods {#s4}
=====================

Protein expression and purification {#s4-1}
-----------------------------------

### Purification of Ubp10-WT and Ubp10 truncations {#s4-1-1}

To make the full-length wild-type Ubp10 expression plasmid (pMN2), the protein coding sequences were amplified from *Saccharomyces cerevisiae* genomic DNA by PCR using KOD polymerase (EMD Millipore). The amplified product containing an N-terminal His6-tag and TEV (tobacco etch virus) cleavage site was inserted into a vector that contains thioredoxin protein, pET32a, using IN-fusion cloning kit (Clontech). Ubp10 N-terminal deletions containing residues 157--792 (pMN3), 200--792 (pMN4), and 250--792 (pMN5), were similarly amplified from the original Ubp10-WT expression plasmid, pMN2, and inserted into pET32a. Ubp10-containing plasmids were expressed in Rosetta (DE3) cells. Briefly, a starter culture was grown to an OD of 0.6, then transferred to 1 L M9ZB medium and allowed to grow at 37°C. When the OD reached \~1.5--2, the medium was supplemented with 1 mM isopropyl-β-D-thiogalactoside (ITPG) and the temperature was shifted to 20°C for an overnight induction. Pelleted cells were lysed in lysis buffer, 25 mM HEPES pH 7.5, 20 mM imidazole pH 7.5, 600 mM NaCl, 10 mM 2-mercaptoethanol, and 1 mM phenylmethylsulfonyl fluoride (PMSF). The lysate was recovered by centrifugation and the supernatant was loaded onto 5 ml HisTrap HP column (GE Healthcare) using buffer A (25 mM HEPES pH 7.5, 20 mM imidazole pH 7.5, 600 mM NaCl, 10 mM 2-mercaptoethanol). Bound protein was eluted with buffer B (25 mM HEPES pH 7.5, 300 mM imidazole pH 7.5, 600 mM NaCl, 10 mM 2-mercaptoethanol). To cleave the purification tags, 1 mg of TEV protease (per mg of protein) was added to the combined fractions and dialyzed overnight against buffer A. The dialyzed sample was then reloaded onto a HisTrap column to remove the cleaved purification tag. The protein was then diluted with ion exchange binding buffer (25 mM HEPES pH 7.5, 50 mM NaCl, 10 mM 2-mercaptoethanol, loaded onto 5 ml Hitrap SP HP column (GE healthcare), and eluted with elution buffer (25 mM HEPES pH 7.5, 1 M NaCl, 10 mM 2-mercaptoethanol). Final purification was carried out using preparative grade HiLoad Superdex 200 26/600 (GE healthcare) with a buffer containing 25 mM HEPES pH 7.5, 250 mM NaCl, and 10 mM 2-mercaptoethanol. All Ubp10 constructs were purified using this protocol. Small aliquots were flash frozen using liquid nitrogen. Although the enzyme is very robust, we avoided freeze thawing for re-use.

### Purification of wild-type histones {#s4-1-2}

*Saccharomyces cerevisiae* histones H2A, H2B, H3, and H4 were expressed in *E.coli* and purified by standard methods ([@bib15]) with modifications as described previously ([@bib50]). All wild-type histone expression plasmids were generous gifts from the laboratory of Greg Bowman.

### Preparation of non-hydrolyzable monoubiquitinated H2B {#s4-1-3}

DUB-resistant monoubiquitinated yH2B containing a dichloroacetone linkage between ubiquitin and H2B-K123 (yH2B-DCA-Ub) was prepared using the approach previously described for *Xenopus* H2B-DCA-Ub ([@bib50]).

### Purification of yeast FACT {#s4-1-4}

All *Saccharomyces cerevisiae* FACT subunits, Nhp6 and the heterodimer of Spt16 and Pob3 were purified from yeast as previously described ([@bib57]; [@bib88]).

Preparation of cleavable monoubiquitinated histone H2B {#s4-2}
------------------------------------------------------

Ubiquitinated yeast H2B was generated semi-synthetically according to protocols previously reported for *Xenopus* H2B-Ub ([@bib50]). In brief, ubiquitin (aa1-76, pMN43) and yH2B (aa1-119, pMN161) were cloned into pTXB1 ([@bib19]; [@bib71]) by making C-terminal fusions with Mxe GyrA intein for thiol-induced cleavage and a chitin binding domain (CBD) for affinity purification using chitin resin (NEB catalog \#S6651L). By using this method, both the ubiquitin and H2B carrying a C-terminal reactive thioester are generated, which can then be used in subsequent ligation reactions. We made minor modifications to the previously used purification steps ([@bib50]). To purify ubiquitin, pMN43 (ubiquitin) was expressed in BL-21 RIL (DE3) cells. A 10-milliliter starter culture was transferred to 1 L 2xYT medium, incubated at 37°C until the OD reached 0.8, and induction was initiated with 0.5 mM IPTG at 16°C overnight. Pelleted cells were lysed in a buffer containing 100 mM NaOAc, 50 mM HEPES pH 6.5, 0.2 mM PMSF and 1 mM TCEP (Tris(2-carboxymethyl)phosphine hydrochloride). The lysate was spun down and the supernatant was loaded on to chitin resin, incubated for two hours to allow binding, and washed with lysis buffer. MES derivatization was initiated by adding cleavage buffer (100 mM NaOAc, 50 mM HEPES pH 6.5, 0.1 mM PMSF and 0.25 mM TCEP, and 250 mM MESNa (Sodium 2-Mercaptoethanesulfonate) and allowed to proceed at 37°C overnight. Cleavage was carried out over 5--6 rounds, each time collecting the derivatized ubiquitin by passing it through the chitin resin. The sample was then purified (twice) on an SP column (GE Healthcare), using binding buffer A (50 mM ammonium acetate pH 4.5, 0.5 mM TCEP) and eluted with 10% buffer B (50 mM ammonium acetate pH 4.5, 1 M NaCl, 0.5 mM TCEP). The final sample was thoroughly dialyzed against 0.5% TFA (Trifluoroacetic acid) and lyophilized. Derivatization was verified by MALDI-TOF mass spectrometry.

To purify histone H2B, pMN161 was expressed in BL-21 RIL (DE3) cells. A 10 ml starter culture was prepared from a freshly transformed plate, grown to an OD of 0.4, transferred and inoculated to an OD of 0.6--0.8 in 500 ml 2xYT medium, then induced overnight at 25°C by addition of 1 mM IPTG. Cells were pelleted by centrifugation, resuspended in 50 mM Tris-HCl pH 7.5, 200 mM NaCl, 1 mM EDTA, 0.1 mM PMSF, protease inhibitor tablet (1 tablet per 50 ml, Roche), and 0.25 mM TCEP, and lysed with a Microfluidizer (Microfluidics). To prevent degradation, the lysate was immediately spun down, the supernatant was applied on to pre-equilibrated chitin resin, and incubated at room temperature for 2--4 hr. The bound protein was washed with lysis buffer, followed by wash buffer 1 (50 mM Tris-HCl pH 7.2, 200 mM NaCl, 1 mM EDTA, 0.1 mM PMSF and 0.25 mM TCEP), and wash buffer 2 (50 mM Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, 0.1 mM PMSF and 0.25 mM TCEP). MES derivatization was performed for 18 hr at 4°C in a buffer containing 50 mM Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, 0.1 mM PMSF, 250 mM MESNa and 0.25 mM TCEP. Cleavage was terminated by adding 20 mM NaOAc pH 5.2, 7 M urea, 1 M NaCl, 1 mM EDTA, 0.1 mM PMSF and 0.25 mM TCEP. The protein was then purified by ion-exchange on an SP column (GE Healthcare) with binding buffer (20 mM NaOAc pH 5.2, 7 M urea, 1 mM EDTA, 0.1 mM PMSF and 0.25 mM TCEP) and eluted with a 0 to 1 M NaCl gradient. Following thorough dialysis against water, the protein was lyophilized and then resuspended in unfolding buffer (7 M Guanidinium-HCl, 20 mM Tris-HCl pH 7.5, and 10 mM DTT). The protein was then purified by HPLC on a C4 column (Higgins Analytical, PROTO C4 5 um 250 × 10 mm) equilibrated with 0.1% TFA and eluted with a 0% to 90% acetonitrile gradient elution. The final sample was then checked for derivatization by MALDI-TOF and immediately lyophilized to prevent hydrolysis.

Synthesis of the C-terminal H2B peptide and ligation of the peptide with H2B and Ub was performed as previously described ([@bib50]) with the following modifications. Briefly, synthetic peptide Cys-H2B(121-130) and purified thioester peptide H2B-(1-119)-MES were ligated using native chemical ligation, followed by unmasking the protected thiolysine with MgCl~2~ and \[Pd(Allyl)Cl\]~2~ ([@bib32]). The ligated product was then treated with DTT, purified via HPLC, and immediately lyophilized. Finally, H2B-(1-130) intermediate was ligated with Ub-MES prepared via intein method and the ligation product was subjected to a desulfurization step, which yielded the desired native H2B-Ub.

Nucleosome reconstitution {#s4-3}
-------------------------

### H2B-Ub containing nucleosomes {#s4-3-1}

Histone octamers and a 146 bp DNA fragment containing the Widom 601 nucleosome positioning sequence were purified and reconstituted into nucleosomes using standard methods ([@bib15]). Nucleosomes containing H2B-DCA-Ub (non-hydrolyzable linkage) and H2B-Ub with the native isopeptide linkage were also reconstituted using the same method and purified using DEAE-5PW column (Tosoh Bioscience). Reconstituted nucleosomes were stored at 4°C and used as needed.

### Flag-tagged yeast nucleosomes {#s4-3-2}

Flag-tagged histone octamers were purified from *E.Coli* using a polycistronic expression vector containing all four yeast histones (a generous gift from Alwin Köhler) and a purification tag on H2B as previously described ([@bib74]). Nucleosomes were reconstituted and purified using standard methods.

Electrophoretic mobility shift assays (EMSAs) {#s4-4}
---------------------------------------------

Ubiquitinated or wild-type nucleosomes (100 nM) and Ubp10 concentrations ranging from 0 to 1600 nM were incubated on ice for 1 hr in the presence of 20 mM HEPES pH 7.6, 50 mM NaCl, 5% sucrose, 1 mM DTT, and 2.5 mM MgCl~2~ and 0.1 mg/ml bovine serum albumin (BSA). Once the reaction was completed, the samples were immediately loaded on to a pre-run 6% Novex TBE gels (Life Technologies) and electrophoresed for 75--100 min using 0.25x TBE running buffer at 4°C. Gels were stained with SYBR gold (Life Technologies) for 20 min and imaged using Chemidoc Touch (Bio-Rad). Apparent dissociation constants were estimated from half-maximal Ubp10-nucleosome complexes on native gel.

Ubp10 deubiquitination activity assays {#s4-5}
--------------------------------------

Deubiquitination activity assays were performed according to a previously described protocol ([@bib50]). Briefly, 1 µM yNCP-Ub and 2 µM yH2A/H2B-Ub were preincubated in a 30°C water bath for 30 min in DUB assay buffer (50 mM HEPES pH 7.6, 150 mM NaCl, and 5 mM DTT). Isopeptidase activity was initiated by adding 5 nM pre-warmed (5 min) Ubp10. Similar concentrations were used for the experiments involving Ubp10 truncations. For experiments involving FACT, 2 µM Nhp6 and 2 µM Spt16/Pob3 were pre-incubated with the substrates. Time-courses were monitored by removing samples at the indicated times and quenching the reactions with 1x-LDS (Bio-Rad). Samples were analyzed on commercial SDS-PAGE gels (NuPAGE and Criterion) stained with SYPRO Ruby and imaged with Chemidoc Touch (Bio-Rad). All experiments were carried out in siliconized low retention tubes (Fisher Scientific Cat. No.02-681-320).

Yeast growth assays {#s4-6}
-------------------

Yeast strains with the genotypes shown in [Table 1](#table1){ref-type="table"} were grown to saturation in rich medium then 10-fold serial dilutions were spotted to agarose plates with the composition described in [Figure 5](#fig5){ref-type="fig"}.

Western blots {#s4-7}
-------------

Western blots were performed as in [@bib49] using the TCA method of protein extraction. Each gel contained a dilution series of the WT strain extract to establish linearity of response and to determine the concentration of the target protein.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000057National Institute of General Medical Sciences GM095822 to Cynthia Wolberger.

-   http://dx.doi.org/10.13039/100000057National Institute of General Medical Sciences GM064649 to Tim Formosa.

-   http://dx.doi.org/10.13039/100000001National Science Foundation Graduate Research Fellowship to Melesse Nune.

-   Jordan and Irene Tark Academic Chair to Ashraf Brik.

-   Israel Council of Higher Education Fellowship to Muhammad Jbara.

-   http://dx.doi.org/10.13039/100000057National Institute of General Medical Sciences Training Grant GM008403 to Melesse Nune.

We thank members of the Wolberger lab for advice and feedback. We are grateful to Anthony DiBello for initially cloning Ubp10 into a bacterial expression plasmid. Funding was provided by National Institutes of Health grants GM095822 (CW) and GM064649 (TF), the Jordan and Irene Tark Academic Chair (AB), an Israel Council of Higher Education Fellowship (MJ), and a National Science Foundation Graduate fellowship (MN).

Additional information {#s5}
======================

Reviewing editor, *eLife*.

Reviewing editor, *eLife*.

No competing interests declared.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing---original draft, Project administration, Writing---review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing---original draft, Project administration, Writing---review and editing.

Resources, Investigation, Methodology.

Supervision, Investigation, Methodology.

Resources, Investigation, Methodology.

Investigation, Involved in the synthesis of mercaptolysine amino acid, a critical reagent for semisynthesis of H2Bub.

Conceptualization, Supervision, Investigation, Methodology, Writing---review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing---original draft, Project administration, Writing---review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing---original draft, Project administration, Writing---review and editing.

Additional files {#s6}
================

10.7554/eLife.40988.019

Data availability {#s7}
-----------------

All data generated or analyzed during this study are included in the manuscript and supporting files.

10.7554/eLife.40988.021

Decision letter

Narlikar

Geeta J

Reviewing Editor

University of California, San Francisco

United States

Studitsky

Vasily M

Reviewer

Fox Chase Cancer Center

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"FACT and Ubp10 collaborate to modulate H2B deubiquitination and nucleosome dynamics\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Geeta Narlikar as Reviewing Editor and Jessica Tyler as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Vasily M Studitsky (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. As you will see the reviewers agree that your work contains new experimental findings that are important for understanding the role of H2B-Ub and histone chaperone FACT in chromatin dynamics during transcription and replication. However they also have some comments that they would like you to address experimentally to strengthen your core conclusions.

Summary:

Histone H2B ubiquitination is a highly conserved PTM coupled to active transcription. Although the enzymes that are involved in the ubiquitination and deubiquitination processes are largely known through genetics, the highly dynamic nature of this PTM has made mechanistic understanding of its function very difficult.

This manuscript reports the surprising finding that histone chaperone FACT is a key regulator of H2B deubiquitinase Ubp10 in yeast. In vitro, FACT strongly stimulates Ubp10 to deubiquitinate nucleosomes, although the underlying mechanism is not entirely clear. In vivo, *ubp10*-Δ and FACT mutants show synthetic effects in HU sensitivity and activation of a cryptic transcription reporter gene, suggesting that they function together in replication and transcription. Since Ubp10 was previously thought to function at subtelomere regions, these results revealed a possible new function of Ubp10 in transcriptionally active coding regions and provide a missing piece of H2Bub dynamics.

Overall the data are of high quality and presented with transparency. The results will be of interest to a broad audience in the transcription/chromatin field. However some key experimental tests are required to strengthen the conclusions as described below. Some textual clarifications are also required.

Essential revisions:

1\) In Figure 2B: 2 μM Spt16/Pob3-WT and 2 μM Nhp6 was used. Is the nucleosome reorganized under these conditions? According to past studies from Formosa lab, typically reorganization requires at least 6-fold molar excess of Nhp6. More importantly does the stimulatory effect of FACT on Ubp10 action require both Spt16/Pob3 and Nhp6 in vitro? Or does FACT facilitate the deubiquitination in the absence of Nhp6 (and thus in the absence of nucleosome reorganization)? This is a critical experiment to further validate the model proposed in Figure 7.

2\) The very detailed proposed model suggests that nucleosome reorganization is necessary for the deubiquitination; however, this remains to be rigorously established (see comment 1). Furthermore, nucleosome reorganization requires the presence of Nhp6 and accordingly the model explicitly implicates Nhp6 in nucleosome reorganization. However, the cycles of ubiquitination/deubiquitination are presumably coupled to ongoing transcription/replication and Nhp6 is generally not present on transcribed genes. Therefore overall, the model should be further clarified and better connected to transcription and replication.

3\) Because Ubp10 has known to function in silencing, there is a formal possibility that *ubp10*-Δ leads to nonspecific spread of the SIR complex, which causes the observed genetic defects. Since the N-terminal regions of Ubp10 is required for its function at subtelomeres, and appears to be dispensable for FACT-dependent activity in vitro, the authors should rescue the synthetic genetic effects with Ubp10 N-terminal truncation mutants.

4\) The result in Figure 4 is surprising. Previously it was reported that inactivating FACT (using a different allele) eliminates H2Bub (Fleming et al., 2008). It\'s possible that this difference is due to allele-specific effects. However, higher levels H2Bub have been shown to associate with better nucleosome assembly (Batta et al., 2011). Figure 6 instead suggests that nucleosome assembly is defective. This contradiction needs to be addressed with more direct evidence (see point 5 below).

5\) Since westerns are notoriously difficult in discerning small differences, a more direct approach would be ChIP analysis of H2B and H2Bub levels across, for example, a long gene previously shown affected by Ubp10. This type of analysis would provide more mechanistic insights as to the effect on nucleosome integrity and relative H2Bub levels (normalized to H2B). It will also separate the effects of ubp10delta at subtelomere vs actively transcribed regions.

6\) The authors propose that FACT can stimulate Ubp10 action on H2B ubiquitylated nucleosomes by either partially unfolding the nucleosome or by dissociating the H2A/H2B dimer. A straightforward way to test for either possibility would be to run the deubiquitylated products on a native gel. If the products run analogous to unmodified nucleosomes this will suggest that FACT transiently unravels the nucleosome but that the nucleosome refolds after deubiquitylation. Instead if the products run analogous to tetrasomes or hexasomes, this will suggest that Ubp10 acts on a free H2A/H2B dimer that is released by FACT action.

7\) While the synthetic interaction is consistent with such a possibility, there is no direct evidence that FACT and Ubp10 function together in vivo. So we suggest that the authors make a statement in the Discussion such as: \"While there is no direct evidence that FACT and Ubp10 work together in vivo, the synthetic genetic interaction and the biochemical cooperation that we observe is consistent with such a possibility\".

10.7554/eLife.40988.022

Author response

> Essential revisions:
>
> 1\) In Figure 2B: 2 μM Spt16/Pob3-WT and 2 μM Nhp6 was used. Is the nucleosome reorganized under these conditions? According to past studies from Formosa lab, typically reorganization requires at least 6-fold molar excess of Nhp6. More importantly does the stimulatory effect of FACT on Ubp10 action require both Spt16/Pob3 and Nhp6 in vitro? Or does FACT facilitate the deubiquitination in the absence of Nhp6 (and thus in the absence of nucleosome reorganization)? This is a critical experiment to further validate the model proposed in Figure 7.

We thank the reviewers for suggesting this experiment. Since yeast Spt16-Pob3 does not bind stably to nucleosomes and is unable to induce nuclease sensitivity without added Nhp6, we had assumed its effects on Ubp10 activity would also have this feature. As shown in the new Figure 2---figure supplement 2 and 4, this assumption was incorrect, as Spt16-Pob3 was able to stimulate Ubp10 activity on nucleosomal H2B-Ub nearly as efficiently without Nhp6 as with it. This has implications for the model regarding how FACT affects Ubp10 activity, and we have made corresponding changes to Figure 7 as a result.

Perhaps more importantly, this result provides more insight into how FACT affects nucleosomal structure, increasing the impact of the results. Human FACT and yeast Spt16-Pob3 do not stably alter nucleosome structure, but each is able to do so with added Nhp6. However, Nhp6 is not essential for viability in yeast, whereas Spt16 and Pob3 are, and human FACT affects RNA Pol II passage under conditions where it does not produce full reorganization. It is therefore clear that Nhp6 is not required for FACT activity, but supports it in vivo and in vitro. Several labs have shown that FACT has multiple domains that interact with histone surfaces, supporting a model in which FACT binds to nucleosomes in several modes. It seems unlikely that producing the fully reorganized form detected by EMSA or restriction endonuclease digestion is the only relevant function of FACT, and we previously proposed a transient \"assembly checkpoint\" form of FACT:nucleosome complexes to explain some genetic and biochemical results (McCullough, et al., 2018). We now propose that one of these modes of binding along the pathway to (or returning from) full reorganization is the form that is relevant for enhancing Ubp10 activity, thus explaining the lack of a requirement for Nhp6 to produce the stably reorganized form. This is significant because it reveals a function for a partially disrupted form of nucleosomes, and because it diminishes the possibility that the stimulation of Ubp10 activity is a simple consequence of H2A-H2B dimer eviction, which does not occur in the absence of Nhp6.

> 2\) The very detailed proposed model suggests that nucleosome reorganization is necessary for the deubiquitination; however, this remains to be rigorously established (see comment 1). Furthermore, nucleosome reorganization requires the presence of Nhp6 and accordingly the model explicitly implicates Nhp6 in nucleosome reorganization. However, the cycles of ubiquitination/deubiquitination are presumably coupled to ongoing transcription/replication and Nhp6 is generally not present on transcribed genes. Therefore overall, the model should be further clarified and better connected to transcription and replication.

The lack of an absolute requirement for Nhp6 in the stimulation of Ubp10 activity on nucleosomal substrates changes our model and our discussion of it as discussed above under point 1. We have also modified the model figure accordingly.

> 3\) Because Ubp10 has known to function in silencing, there is a formal possibility that ubp10-Δ leads to nonspecific spread of the SIR complex, which causes the observed genetic defects. Since the N-terminal regions of Ubp10 is required for its function at subtelomeres, and appears to be dispensable for FACT-dependent activity in vitro, the authors should rescue the synthetic genetic effects with Ubp10 N-terminal truncation mutants.

Richard Gardner\'s lab identified Ubp10 residues 109-133 as the region necessary for interaction with the SIR complex and showed that the *ubp10-∆(109-133)* allele exhibited a silencing defect comparable to *ubp10∆* (Reed et al., 2015). We deleted these residues from the native *UBP10* locus using a markerless conversion method (Storici et al., Nat Biotechnol, 2001 19:773), combined the *ubp10-∆(109-133)* allele with FACT mutations, and repeated our genetic analysis. The mutation lacking the SIR-interaction domain did not affect the properties of FACT mutants in the manner observed for the full deletion of *UBP10*, ruling out the possibility that the phenotypes we observe are caused by the function of Ubp10 in silencing. We show the results for the *pob3-L78R* allele in Figure 6---figure supplement 1.

> 4\) The result in Figure 4 is surprising. Previously it was reported that inactivating FACT (using a different allele) eliminates H2Bub (Fleming et al., 2008). It\'s possible that this difference is due to allele-specific effects. However, higher levels H2Bub have been shown to associate with better nucleosome assembly (Batta et al., 2011). Figure 6 instead suggests that nucleosome assembly is defective. This contradiction needs to be addressed with more direct evidence (see point 5 below).

We have found that strains with the *spt16-G132D* allele used by Fleming et al. have normal levels of Pob3 but reduced Spt16 under permissive conditions, whereas *pob3-L78R* strains have about a 10-fold reduction in Pob3 but nearly normal levels of Spt16 (VanDemark, et al., 2008). Both alleles therefore examine cells with reduced FACT levels; however, one goes from normal to very low FACT (*spt16-G132D = spt16-197; acute withdrawal*) while the other has chronically low FACT throughout the experiment. Further, the balance of Spt16 to Pob3 is expected to be different in the two strains. Since complete withdrawal of FACT is ultimately lethal, we think the use of chronic reduction under viable conditions is preferable to complete inactivation of Spt16 at a non-permissive temperature. Overall, we do not know why Fleming et al. observed decreased FLAG-H2B-ub levels under conditions of lethal withdrawal of FACT using the *spt16-G132D* allele, but we are confident that H2B-Ub increases under chronic Pob3 depletion with *pob3-L78R*. Moreover, we claim that *pob3L78R* affects Ubp10 activity in vivo, not that all FACT defects do. We have added these ideas to the manuscript (subsection "A FACT mutant strain has elevated levels of H2B-Ub", last paragraph).

The data from Batta et al., 2011, show a more complex picture than a simple association of higher H2B-Ub with greater nucleosome occupancy. While that study shows a global decrease in nucleosome occupancy for an H2B-K123A mutation, that mutant cannot undergo cycles of H2B ubiquitination/deubiquitination and is presumably defective in FACT recruitment, all of which are thought to be important for maintaining chromatin organization (Batta et al., 2011; Fleming et al., 2008; Henry et al., 2003; Pavri et al., 2006). The decrease in global nucleosome occupancy observed in deletions of the H2B E2 ubiquitin conjugating enzyme (Rad6) and associated factor (Lge1, which binds to the E3 ligase, Bre1), and increase in global nucleosome occupancy observed in a *ubp8*D deletion is consistent with a role for H2B-Ub in stabilizing nucleosomes (the effects of *ubp10*D were not examined). However, the simple model that high global levels of H2BUb correlate with higher nucleosome occupancy is contradicted by their observation that highly transcribed genes have normal levels of nucleosome occupancy in a *ubp8∆* mutant, even though these genes have markedly lower nucleosome occupancy in *rad6∆* and H2B-K123A mutants (Batta et al., 2011). The relationship between global H2B-Ub levels and nucleosome occupancy is thus clearly complex. Our model that both ubiquitination and deubiquitination are important for maintaining chromatin structure and that Ubp10 and FACT function together in this process is consistent the general consensus that cycles of H2B ubiquitination and deubiquitination are critical to maintaining chromatin organization. We have added a paragraph to the Discussion (third paragraph) that summarizes these points.

> 5\) Since westerns are notoriously difficult in discerning small differences, a more direct approach would be ChIP analysis of H2B and H2Bub levels across, for example, a long gene previously shown affected by Ubp10. This type of analysis would provide more mechanistic insights as to the effect on nucleosome integrity and relative H2Bub levels (normalized to H2B). It will also separate the effects of ubp10delta at subtelomere vs actively transcribed regions.

We believe that the western blot data we are presenting meet a much higher standard of stringency than those presented in the Fleming paper (see response to point 4 above). We agree that quantitation of western blots with histones can be difficult, but we note that we used stringent methods including a dilution series on every blot to establish linearity of all responses (with an example shown in our figure), and we report quantitative results from at least 13 independent replicates. This is in contrast to the result reported by Fleming et al. who based their conclusion on visual inspection of a single lane from a single western without quantitation or normalization. Further, their strain carried a deletion of the two H2B genes covered with a plasmid expressing FLAG-tagged H2B (H2B-FLAG). It also had a deletion of *SPT16* covered with an *spt16-G132D* plasmid; our published work shows that each of these manipulations can lead to misregulation of at least some genes, so we instead used modifications of native loci in our experiments (unperturbed H2B genes with H2B and H2B-Ub detected by separate specific antibodies, and an otherwise unperturbed *POB3* locus with just the L78R mutation.) We are therefore much more confident that this allele of FACT leads to elevated H2B-Ub than we are confident that *spt16-G132D* grown at the non-permissive temperature leads to its loss.

We think that western blots provide the appropriate global information we need to ask a question about the effects of Ubp10, which we propose acts genome-wide for producing global chromatin architecture, whereas Ubp8 acts locally in the context of transcription. Western blots measure the global level of H2B-Ub whereas ChIP measures local levels, which are known to vary at different sites relative to the transcription start site, as discussed in several places in this manuscript. Using ChIP to answer this question assumes that we know which loci should be affected and which should not, but this in turn assumes a model in which ubiquitination exclusively supports nucleosome stability and that loss of Ubp10 will have predictable effects localized to the same genes whose transcription is altered by this mutation. As discussed below, these assumptions may not be valid, and testing them is beyond the scope of this manuscript. Our claim is that a FACT defect can cause global loss of deubiquitination of H2B by Ubp10; we do not know or claim to know where this failure occurs.

To address the reviewers' suggestion, we used anti-H2B-Ub ChIP to test several genes (PMA1, the HO promoter, 5\' end, and 3\' end, and PHO89) of different sizes whose transcript levels change in different ways in a *ubp10∆* strain, but we did not see a uniform pattern of effects. H2B-Ub levels were unaffected by any mutation in PMA1, they were elevated in the promoter and 5\' end of the *HO* gene in a *pob3-L78R* strain but not in a *ubp10∆* strain, and they increased at the 3\' end of *HO* in both mutants. Selected regions therefore support the model that FACT collaborates with Ubp10, but the story is clearly more complex. The initial rationale for attempting this approach was that it is difficult to use western blots to detect small changes in H2B-Ub, but ChIP introduces variation from both the antibody capture of material and using exponential PCR to detect small changes. We used 4 biological replicates of each strain and 4 technical replicates of each IP in our tests and observed more variation among the results than we did with western blots, not less. We therefore conclude that our western blot data meet the highest standard of stringency for this method, answer the question we are asking, and are more reliable for this purpose than ChIP.

The ChIP-qPCR approach is also less suitable for our needs than westerns because there is no suitable commercially available anti-H2B antibody available for ChIP, so we cannot normalize the H2B-Ub levels to the H2B levels without resorting to using an epitope tag that disrupts the phenomenon we are measuring. Our tests show that supplying FLAG-tagged H2B affects the phenotypes of FACT mutants, making this an unacceptable alternative. Overall, the only way to pursue the interesting effects we have observed is to do a ChIP-seq experiment and compare the outcomes to nucleosome occupancy and positioning by MNase-seq. We are considering initiating these studies, but they are clearly beyond the scope of this revision.

> 6\) The authors propose that FACT can stimulate Ubp10 action on H2B ubiquitylated nucleosomes by either partially unfolding the nucleosome or by dissociating the H2A/H2B dimer. A straightforward way to test for either possibility would be to run the deubiquitylated products on a native gel. If the products run analogous to unmodified nucleosomes this will suggest that FACT transiently unravels the nucleosome but that the nucleosome refolds after deubiquitylation. Instead if the products run analogous to tetrasomes or hexasomes, this will suggest that Ubp10 acts on a free H2A/H2B dimer that is released by FACT action.

We have performed the suggested experiment, which is shown in Figure 2---figure supplement 4. The results show that the presence of FACT during the deubiquitination assay has no effect on the mobility of the three nucleosome species (with 2, 1 or 0 ubiquitins), indicating that the nucleosomes remain intact. This result suggests that FACT\'s effects on the nucleosomes that stimulate the activity of Ubp10 are transient and reversible.

> 7\) While the synthetic interaction is consistent with such a possibility, there is no direct evidence that FACT and Ubp10 function together in vivo. So we suggest that the authors make a statement in the Discussion such as: \"While there is no direct evidence that FACT and Ubp10 work together in vivo, the synthetic genetic interaction and the biochemical cooperation that we observe is consistent with such a possibility\".

This statement has been added to the Discussion.
